Stockreport

Aethlon Medical signals faster clinical trial enrollment amid Hemopurifier advancements [Seeking Alpha]

Aethlon Medical, Inc.  (AEMD) 
NASDAQ:AMEX Investor Relations: ir.aethlonmedical.com
PDF James Frakes, CEO and CFO, stated that Aethlon Medical continues to execute its strategy of advancing the Hemopurifier platform while maintaining disciplined cost contr [Read more]